Phase II study of targeted therapy with temozolomide in acute myeloid leukaemia and high-risk myelodysplastic syndrome patients pre-screened for low O6-methylguanine DNA methyltransferase expression
2014 ◽
Vol 167
(5)
◽
pp. 664-670
◽
2007 ◽
Vol 138
(4)
◽
pp. 555-557
◽
2017 ◽
Vol 180
(3)
◽
pp. 346-355
◽
2015 ◽
Vol 2
(10)
◽
pp. e396-e397
◽
Keyword(s):